t radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves’ disease. Thyroid 9:775.
59.2. Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Gravesâ€™ hyperthyroidism: one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 86:3488-3493, 2001.
59.3. Burch HB, Solomon BL, Cooper DS, Ferguson P, Walpert N, Howard R. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after 131-I ablation for Gravesâ€™ disease. J Clin Endocrinol Metab 86:3016-3021, 2001.
59.4: Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedus L. Propylthiouracil before 131-I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial.J Clin Endocrinol Metab. 2004 Sep;89(9):4439-44.
60. Greig WR, Gillespie FC, Thomson JA, McGirr EM: Iodine-125 treatment for thyrotoxicosis. Lancet 1:755, 1969.
61. Editorial: Radioiodine treatment of thyrotoxicosis. Lancet 1:23,1972.
62. Bremmer WF, Greig WR, McDougall IR: Results of treating 297 thyrotoxic patients with 125I. Lancet 2:281, 1973.
63. Benua RS, Dobyns BM: Isolated compounds in the serum, disappearance of radioactive iodine from the thyroid, and clinical response in patients treated with radioactive iodine. J Clin Endocrinol Metab 15:118, 1955.
63.1. Stensvold AD, Jorde R, Sundsfjord J. Late and transient increases in free T4 after radioiodine treatment for Gravesâ€™ disease. J Endocrinol Invest 20:580-584, 1997.
64. Stanbury JB, Janssen MA: The iodinated albumin-like component of the plasma of thyrotoxic patients. J Clin Endocrinol Metab 22:978, 1962. 64a. Dale J, Daykin J, Holder R, Sheppard MC, Franklyn JA. Weight gain following treatment of hyperthyroidism. Clin Endocrinol 55:233-239, 2001.
65. Goldsmith RE: Radioisotope therapy for Graves’ disease. Mayo Clin Proc 47:953, 1972.
66. Slingerland WD, Hershman JM, Dell E, Burrows B: Thyrotropin and PBI in radioiodine-treated hyperthyroid patients. J Clin Endocrinol Metab 35:912, 1972.
67. Gordin A, Wagar G, HernbergCA: Serum thyrotropin and response to thyrotrophin-releasing hormone in patients who are euthyroid after radioiodine treatment for hyperthyroidism. Acta Med Scand 194:335, 1973.
68. Baldwin WW: Graves’ disease succeeded by atrophy. Lancet 1:145,1895.
69. Wood LC, Ingbar SH: Hypothyroidism as a late sequela in patients with Graves’ disease treated with antithyroid drugs. J Clin Invest 64:1429, 1979. 69a. Tigas S, Idiculla J, Beckett G, Toft A. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Thyroid 10:1107, 2000.
70. Creutzig H, Kallfelz I, Haindl J, Thiede G, Hundeshagen H: Thyroid storm and iodine-131 treatment. Lancet 2:145, 1976.
71. Creutzig H, Kallfelz I, Haindl J, Thiede G, Hundeshagen H: Thyroid storm and iodine-131 treatment. Lancet 2:145, 1976.
72. Lamberg BA, HernbergCA, Wahlberg P, Hakkila R: Treatment of toxic nodular goiter with radioactive iodine. Acta Med Scand 165:245, 1959.
73. McDermott MT, Kidd GS, Dodson Jr LE, Hofeldt FD: Radioiodine-induced thyroid storm. Case report and literature review. Amer J Med 75:353, 1983.
74. Townsend JD: Hypoparathyroidism following radioactive iodine therapy for intractable angina pectoris. Ann Intern Med 55:662, 1961.
75. Gilbert-Dreyfus MZ, Gali P: Cataract due to tetany following radioactive iodine therapy. Sem Hop Paris 34:1301, 1958.
76. Fulop M: Hypoparathyroidism after 131-I therapy. Ann Intern Med 75:808, 1971. 76.1 Ceccarelli C, Canale D, Battisti P, Caglieresi C, Moschini C, Fiore E, Grasso L, Pinchera A, Vitti P.Testicular function after 131-I therapy for hyperthyroidism.Clin Endocrinol (Oxf). 2006 Oct;65(4):446-52. 76a. Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA. 2005 Jul 6;294(1):71-80.
77. Fenzi G, Hashizume K, Roudebush C, DeGroot LJ: Changes in thyroid stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab 48:572, 1979.
78. Teng CS, Yeung RTT